Source: Medicines Authority (MT) Revision Year: 2022 Publisher: TAD Pharma GmbH, Heinz-Lohmann-Straรe 5, 27472 Cuxhaven, Germany
Monkasta 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. The film-coated tablets are apricot-coloured, round, slightly biconvex, with bevelled edges. |
Each film-coated tablet contains 10 mg montelukast (as montelukast sodium).
Excipient(s) with known effect: Each film-coated tablet contains 81.94 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Montelukast |
Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor. ฮคhe CysLT type-1 (CysLT1) receptor is found in the human airway (including airway smooth muscle cells and airway macrophages) and on other pro-inflammatory cells (including eosinophils and certain myeloid stem cells). CysLTs have been correlated with the pathophysiology of asthma and allergic rhinitis. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Film-coating: Hypromellose (E464) |
Blister (OPA/Alu/PVC//Alu), pack sizes: 7, 10, 14, 20, 28, 30, 49, 50, 56, 84, 90, 98, 100, 140 or 200 film-coated tablets, in a box.
Not all pack sizes may be marketed.
TAD Pharma GmbH, Heinz-Lohmann-Straรe 5, 27472 Cuxhaven, Germany
MA982/01002
Date of first authorisation: 17th February 2022
| Drug | Countries | |
|---|---|---|
| MONKASTA | Germany, Estonia, Spain, Croatia, Italy, Lithuania, Malta, Poland, Romania |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
